BIOSENIC SA (BIOS.BR) Stock Overview
EBR:BIOS - BE0974280126 - Common Stock
BIOS.BR Key Statistics, Chart & Performance
The current stock price of BIOS.BR is 0.003 EUR. In the past month the price increased by 4.17%. In the past year, price decreased by -71.91%.
BIOS.BR Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| 4AB.DE | ABBVIE INC | 19.45 | 312.65B | ||
| AMG.DE | AMGEN INC | 13.74 | 138.41B | ||
| GIS.DE | GILEAD SCIENCES INC | 15.05 | 124.21B | ||
| VX1.DE | VERTEX PHARMACEUTICALS INC | 23.4 | 87.44B | ||
| ARGX.BR | ARGENX SE | 76.23 | 34.61B | ||
| 22UA.DE | BIONTECH SE-ADR | N/A | 22.96B | ||
| IDP.DE | BIOGEN INC | 8.73 | 17.60B | ||
| 0QF.DE | MODERNA INC | N/A | 9.04B | ||
| 1MRNA.MI | MODERNA INC | N/A | 8.98B | ||
| ABVX.PA | ABIVAX SA | N/A | 5.01B | ||
| 1VKTX.MI | VIKING THERAPEUTICS INC | N/A | 2.47B | ||
| GLPG.AS | GALAPAGOS NV | N/A | 1.82B |
Related stock screener links
About BIOS.BR
Company Profile
BioSenic SA is a biotech company engaged in the development of clinical assets . The company is headquartered in Mont-Saint-Guibert, Brabant-Wallon and currently employs 11 full-time employees. The company went IPO on 2015-02-06. The firm develops cell therapy products for the treatment and regeneration of bone tissue and bone reconstruction applications, osteonecrosis, ununited fractures, and maxillo-facial reconstruction. The company is engaged in research, enable adult stem cell isolation, expansion, and osteogenic differentiation. The Company’s therapeutic area focus is bone diseases, with extensions to joint, mainly osteoarthritis and disc degeneration. The company also provides cell therapy platform for tissue repair protection with an entirely new arsenal of various anti-inflammatory and anti-autoimmune formulations using the immunomodulatory properties of ATO/OATO (Arsenic trioxide/ Oral arsenic trioxide).
Company Info
BIOSENIC SA
Rue Granbonpre 11, Batiment H (bte 24)
Mont-Saint-Guibert BRABANT-WALLON BE
Employees: 11
Phone: 32493097366
BIOSENIC SA / BIOS.BR FAQ
What is the stock price of BIOSENIC SA today?
The current stock price of BIOS.BR is 0.003 EUR. The price increased by 20% in the last trading session.
What is the ticker symbol for BIOSENIC SA stock?
The exchange symbol of BIOSENIC SA is BIOS and it is listed on the Euronext Brussels exchange.
On which exchange is BIOS.BR stock listed?
BIOS.BR stock is listed on the Euronext Brussels exchange.
What is BIOSENIC SA worth?
BIOSENIC SA (BIOS.BR) has a market capitalization of 1.96M EUR. This makes BIOS.BR a Nano Cap stock.
How many employees does BIOSENIC SA have?
BIOSENIC SA (BIOS.BR) currently has 11 employees.
Should I buy BIOSENIC SA (BIOS.BR) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of BIOS.BR, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of BIOS.BR, evaluating the profitability, health, valuation and growth aspects
- BIOSENIC SA (BIOS.BR) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- BIOSENIC SA (BIOS.BR) Sales and EPS estimates to see what analysts future expectations are.
- BIOSENIC SA (BIOS.BR) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- BIOSENIC SA (BIOS.BR) Insider and Institutional Ownership to learn about the owners and their transactions.
- BIOSENIC SA (BIOS.BR) Stock Chart to make your own analysis
- BIOSENIC SA (BIOS.BR) Latest news and press-releases to stay up to date.
Does BIOSENIC SA (BIOS.BR) stock pay dividends?
BIOS.BR does not pay a dividend.
When does BIOSENIC SA (BIOS.BR) report earnings?
BIOSENIC SA (BIOS.BR) will report earnings on 2025-09-30.
BIOS.BR Technical Analysis
ChartMill assigns a technical rating of 5 / 10 to BIOS.BR. When comparing the yearly performance of all stocks, BIOS.BR is a bad performer in the overall market: 87.79% of all stocks are doing better.
BIOS.BR Financial Highlights
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | N/A | ||
| ROE | N/A | ||
| Debt/Equity | N/A |